Anpario says premium products boost profit as revenue rises 7%
Anpario reported revenue up 7% to £24.3m, with growth led by IMEA and the Americas while Asia declined due to toxin binder weakness. Adjusted EBITDA rose 22% and EPS increased 30%; H2 profit expectations remain unchanged despite a softer start.